Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-08

AUTHORS

T Ahmadi, J McQuade, D Porter, N Frey, A W Loren, S C Goldstein, J Svoboda, E Stadtmauer, S J Schuster, S D Nasta

ABSTRACT

We retrospectively analyzed 44 patients undergoing first-line treatment for mantle cell lymphoma with R-HyperCVAD, with or without rituximab (R) maintenance or auto-SCT. The primary study end point was PFS; secondary end point was overall survival.Median follow up for all patients was 3.3 years. Median age was 54 years, and 95% (n=42) were stage III or IV at diagnosis. In all, 17 patients underwent consolidative auto-SCT and 12 patients received R maintenance. The overall response rate was 95%, with 91% achieving complete response (CR). Median PFS for all patients was 3.5 years. Median PFS was 2.3 years for patients treated with R-HyperCVAD alone vs 3.9 years (P=0.02) with R-HyperCVAD+ R maintenance and 4.5 years (P=0.01) with R-HyperCVAD+ auto-SCT. For patients who did not achieve CR at interim staging, PFS for R-HyperCVAD alone was 1.4 years vs not reached for R-HyperCVAD+ consolidation (either R maintenance or auto-SCT) (P=0.02). PFS for patients with CR at interim staging was 3.3 years vs not reached (P=0.04) after consolidation. Our data suggest potential improvement in PFS when R-HyperCVAD is consolidated with either R maintenance or auto-SCT. This benefit appears particularly significant in those patients who do not achieve CR at interim restaging. More... »

PAGES

1082

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bmt.2011.218

DOI

http://dx.doi.org/10.1038/bmt.2011.218

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1006686198

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22080969


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Murine-Derived", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphoma, Mantle-Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rituximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Autologous", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ahmadi", 
        "givenName": "T", 
        "id": "sg:person.01240050411.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240050411.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Department of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McQuade", 
        "givenName": "J", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Porter", 
        "givenName": "D", 
        "id": "sg:person.0707416147.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707416147.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Frey", 
        "givenName": "N", 
        "id": "sg:person.01342471137.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342471137.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Loren", 
        "givenName": "A W", 
        "id": "sg:person.0613365041.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613365041.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goldstein", 
        "givenName": "S C", 
        "id": "sg:person.016115210252.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016115210252.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Svoboda", 
        "givenName": "J", 
        "id": "sg:person.0722677225.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722677225.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stadtmauer", 
        "givenName": "E", 
        "id": "sg:person.01044042041.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schuster", 
        "givenName": "S J", 
        "id": "sg:person.014567760612.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014567760612.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pennsylvania", 
          "id": "https://www.grid.ac/institutes/grid.25879.31", 
          "name": [
            "Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nasta", 
        "givenName": "S D", 
        "id": "sg:person.01001105007.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001105007.49"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1182/blood-2006-05-021113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001773472"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2010.08228.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004342869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2010.08228.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004342869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2141.2003.04140.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011769252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.08.133", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012126812"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-03-147025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014062347"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdl127", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018683246"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.164", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024531918"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2002-08-2476", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025513720"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.17.1561", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036111565"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.01.1825", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036898047"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2004-10-3883", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040043539"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.2403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045509899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.11838", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052550962"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.16.8435", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053491476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2006-04-016725", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053696274"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.20.5.1288", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064202851"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.08.674", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203113"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076949215", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/oxfordjournals.annonc.a059155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082434789"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1998.16.8.2780", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083306001"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-08", 
    "datePublishedReg": "2012-08-01", 
    "description": "We retrospectively analyzed 44 patients undergoing first-line treatment for mantle cell lymphoma with R-HyperCVAD, with or without rituximab (R) maintenance or auto-SCT. The primary study end point was PFS; secondary end point was overall survival.Median follow up for all patients was 3.3 years. Median age was 54 years, and 95% (n=42) were stage III or IV at diagnosis. In all, 17 patients underwent consolidative auto-SCT and 12 patients received R maintenance. The overall response rate was 95%, with 91% achieving complete response (CR). Median PFS for all patients was 3.5 years. Median PFS was 2.3 years for patients treated with R-HyperCVAD alone vs 3.9 years (P=0.02) with R-HyperCVAD+ R maintenance and 4.5 years (P=0.01) with R-HyperCVAD+ auto-SCT. For patients who did not achieve CR at interim staging, PFS for R-HyperCVAD alone was 1.4 years vs not reached for R-HyperCVAD+ consolidation (either R maintenance or auto-SCT) (P=0.02). PFS for patients with CR at interim staging was 3.3 years vs not reached (P=0.04) after consolidation. Our data suggest potential improvement in PFS when R-HyperCVAD is consolidated with either R maintenance or auto-SCT. This benefit appears particularly significant in those patients who do not achieve CR at interim restaging.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bmt.2011.218", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "47"
      }
    ], 
    "name": "Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance", 
    "pagination": "1082", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1fd9589446f549e31ea3bcb31a09434b91c22145694b8b11a57ce794e2a64b05"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22080969"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8702459"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bmt.2011.218"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1006686198"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bmt.2011.218", 
      "https://app.dimensions.ai/details/publication/pub.1006686198"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:09", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8675_00000435.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bmt2011218"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bmt.2011.218'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bmt.2011.218'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bmt.2011.218'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bmt.2011.218'


 

This table displays all metadata directly associated to this object as RDF triples.

255 TRIPLES      21 PREDICATES      65 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bmt.2011.218 schema:about N025a35feed204c1badcea78e8dc3e6f0
2 N030fec9d22ca4129ae0db5ff5d0fe952
3 N0adce029a5774e20884fac13684f3087
4 N1578fa82ae444641bd4057aa3738ed42
5 N28d42a9e1b494f7f85278a6309fa74cf
6 N6a573d5c794a4a5fade1d14798e1a473
7 N75f44f27227740d8a760bcc28e52bf95
8 N810f6ee31e9a4b56a8212b5dd95bb2f1
9 N92ba9f969cf24bdbb82d831911b83295
10 N9566f8ed8ebe41c5b83cf3a035292fb5
11 Na1136017f9f84ce0a2cd45a94dfc8139
12 Ncaac76df64314f79ae3e1ac14c6694e6
13 Nd27c1dd357d44eef9754f95c0e9835bc
14 Ne1b0c7b7565e4e328ac27456604b89de
15 Neb79517fa082415facfe87abe2210983
16 Nf052c15ce55c4a1c8a078768ea0e17ed
17 anzsrc-for:11
18 anzsrc-for:1112
19 schema:author N7537e2894a774d5384833c95254b9bbf
20 schema:citation https://app.dimensions.ai/details/publication/pub.1076949215
21 https://doi.org/10.1002/cncr.11838
22 https://doi.org/10.1046/j.1365-2141.2003.04140.x
23 https://doi.org/10.1093/annonc/mdl127
24 https://doi.org/10.1093/oxfordjournals.annonc.a059155
25 https://doi.org/10.1111/j.1365-2141.2010.08228.x
26 https://doi.org/10.1182/blood-2002-08-2476
27 https://doi.org/10.1182/blood-2004-10-3883
28 https://doi.org/10.1182/blood-2006-04-016725
29 https://doi.org/10.1182/blood-2006-05-021113
30 https://doi.org/10.1182/blood-2008-03-147025
31 https://doi.org/10.1200/jco.1998.16.8.2780
32 https://doi.org/10.1200/jco.20.5.1288
33 https://doi.org/10.1200/jco.2002.08.674
34 https://doi.org/10.1200/jco.2005.01.1825
35 https://doi.org/10.1200/jco.2005.04.164
36 https://doi.org/10.1200/jco.2005.08.133
37 https://doi.org/10.1200/jco.2006.09.2403
38 https://doi.org/10.1200/jco.2008.16.8435
39 https://doi.org/10.1200/jco.2008.17.1561
40 schema:datePublished 2012-08
41 schema:datePublishedReg 2012-08-01
42 schema:description We retrospectively analyzed 44 patients undergoing first-line treatment for mantle cell lymphoma with R-HyperCVAD, with or without rituximab (R) maintenance or auto-SCT. The primary study end point was PFS; secondary end point was overall survival.Median follow up for all patients was 3.3 years. Median age was 54 years, and 95% (n=42) were stage III or IV at diagnosis. In all, 17 patients underwent consolidative auto-SCT and 12 patients received R maintenance. The overall response rate was 95%, with 91% achieving complete response (CR). Median PFS for all patients was 3.5 years. Median PFS was 2.3 years for patients treated with R-HyperCVAD alone vs 3.9 years (P=0.02) with R-HyperCVAD+ R maintenance and 4.5 years (P=0.01) with R-HyperCVAD+ auto-SCT. For patients who did not achieve CR at interim staging, PFS for R-HyperCVAD alone was 1.4 years vs not reached for R-HyperCVAD+ consolidation (either R maintenance or auto-SCT) (P=0.02). PFS for patients with CR at interim staging was 3.3 years vs not reached (P=0.04) after consolidation. Our data suggest potential improvement in PFS when R-HyperCVAD is consolidated with either R maintenance or auto-SCT. This benefit appears particularly significant in those patients who do not achieve CR at interim restaging.
43 schema:genre research_article
44 schema:inLanguage en
45 schema:isAccessibleForFree true
46 schema:isPartOf N0a848ef7957d4b3b891f53eb6f33a56c
47 N8c9d9b1996ac449b83b1d0a55a3f686b
48 sg:journal.1096890
49 schema:name Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance
50 schema:pagination 1082
51 schema:productId N2affad73987c4f7b9ac44120168a5520
52 N4a2c6e34f5804b8b90afea70a29a2a63
53 N51fc9dd5fb454a67952abfbbb49a8d8c
54 N5b06855a5c2746d7a94db876d9a60a14
55 N9a40ff2d51e44f53b2304873763c46cc
56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006686198
57 https://doi.org/10.1038/bmt.2011.218
58 schema:sdDatePublished 2019-04-10T18:09
59 schema:sdLicense https://scigraph.springernature.com/explorer/license/
60 schema:sdPublisher Nb8a2ecf6340b402987aba2d4395163ee
61 schema:url https://www.nature.com/articles/bmt2011218
62 sgo:license sg:explorer/license/
63 sgo:sdDataset articles
64 rdf:type schema:ScholarlyArticle
65 N025a35feed204c1badcea78e8dc3e6f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Middle Aged
67 rdf:type schema:DefinedTerm
68 N030fec9d22ca4129ae0db5ff5d0fe952 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Time Factors
70 rdf:type schema:DefinedTerm
71 N0a848ef7957d4b3b891f53eb6f33a56c schema:issueNumber 8
72 rdf:type schema:PublicationIssue
73 N0adce029a5774e20884fac13684f3087 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Humans
75 rdf:type schema:DefinedTerm
76 N1578fa82ae444641bd4057aa3738ed42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Disease-Free Survival
78 rdf:type schema:DefinedTerm
79 N28d42a9e1b494f7f85278a6309fa74cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Rituximab
81 rdf:type schema:DefinedTerm
82 N2affad73987c4f7b9ac44120168a5520 schema:name readcube_id
83 schema:value 1fd9589446f549e31ea3bcb31a09434b91c22145694b8b11a57ce794e2a64b05
84 rdf:type schema:PropertyValue
85 N3cf84838141e40a7805f2cc16eed38be rdf:first sg:person.01342471137.57
86 rdf:rest N9370b4227f604a8fa4847e80bbcab16b
87 N47466f1fcdb242fe94e4dc09dec4eb6b rdf:first sg:person.016115210252.03
88 rdf:rest N5478a75237a544bf8e88dac21d94c8ee
89 N4a2c6e34f5804b8b90afea70a29a2a63 schema:name nlm_unique_id
90 schema:value 8702459
91 rdf:type schema:PropertyValue
92 N51fc9dd5fb454a67952abfbbb49a8d8c schema:name dimensions_id
93 schema:value pub.1006686198
94 rdf:type schema:PropertyValue
95 N5478a75237a544bf8e88dac21d94c8ee rdf:first sg:person.0722677225.98
96 rdf:rest N7a86e483463140a3a7532822e02cb0b5
97 N5b06855a5c2746d7a94db876d9a60a14 schema:name doi
98 schema:value 10.1038/bmt.2011.218
99 rdf:type schema:PropertyValue
100 N6a573d5c794a4a5fade1d14798e1a473 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Male
102 rdf:type schema:DefinedTerm
103 N7537e2894a774d5384833c95254b9bbf rdf:first sg:person.01240050411.42
104 rdf:rest Nf79036290b944c238c50b6d8bd067e66
105 N75f44f27227740d8a760bcc28e52bf95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Transplantation, Autologous
107 rdf:type schema:DefinedTerm
108 N7a86e483463140a3a7532822e02cb0b5 rdf:first sg:person.01044042041.97
109 rdf:rest N9bc4f1f9b3bd40379e9828e82a1ef61b
110 N7f861cd28e094943bdeed1302a2b08a3 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
111 schema:familyName McQuade
112 schema:givenName J
113 rdf:type schema:Person
114 N810f6ee31e9a4b56a8212b5dd95bb2f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Lymphoma, Mantle-Cell
116 rdf:type schema:DefinedTerm
117 N8c9d9b1996ac449b83b1d0a55a3f686b schema:volumeNumber 47
118 rdf:type schema:PublicationVolume
119 N92ba9f969cf24bdbb82d831911b83295 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Antibodies, Monoclonal, Murine-Derived
121 rdf:type schema:DefinedTerm
122 N9370b4227f604a8fa4847e80bbcab16b rdf:first sg:person.0613365041.61
123 rdf:rest N47466f1fcdb242fe94e4dc09dec4eb6b
124 N9566f8ed8ebe41c5b83cf3a035292fb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Follow-Up Studies
126 rdf:type schema:DefinedTerm
127 N9a40ff2d51e44f53b2304873763c46cc schema:name pubmed_id
128 schema:value 22080969
129 rdf:type schema:PropertyValue
130 N9bc4f1f9b3bd40379e9828e82a1ef61b rdf:first sg:person.014567760612.40
131 rdf:rest Ne9ec90612ee74434a6c5ec1520c9c287
132 Na1136017f9f84ce0a2cd45a94dfc8139 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Retrospective Studies
134 rdf:type schema:DefinedTerm
135 Nb8a2ecf6340b402987aba2d4395163ee schema:name Springer Nature - SN SciGraph project
136 rdf:type schema:Organization
137 Ncaac76df64314f79ae3e1ac14c6694e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Survival Rate
139 rdf:type schema:DefinedTerm
140 Nd27c1dd357d44eef9754f95c0e9835bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Neoplasm Staging
142 rdf:type schema:DefinedTerm
143 Ne1b0c7b7565e4e328ac27456604b89de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Antineoplastic Combined Chemotherapy Protocols
145 rdf:type schema:DefinedTerm
146 Ne9ec90612ee74434a6c5ec1520c9c287 rdf:first sg:person.01001105007.49
147 rdf:rest rdf:nil
148 Neb79517fa082415facfe87abe2210983 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Stem Cell Transplantation
150 rdf:type schema:DefinedTerm
151 Nf052c15ce55c4a1c8a078768ea0e17ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Female
153 rdf:type schema:DefinedTerm
154 Nf194e1ed01b3450e931ed1e476d27bd0 rdf:first sg:person.0707416147.15
155 rdf:rest N3cf84838141e40a7805f2cc16eed38be
156 Nf79036290b944c238c50b6d8bd067e66 rdf:first N7f861cd28e094943bdeed1302a2b08a3
157 rdf:rest Nf194e1ed01b3450e931ed1e476d27bd0
158 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
159 schema:name Medical and Health Sciences
160 rdf:type schema:DefinedTerm
161 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
162 schema:name Oncology and Carcinogenesis
163 rdf:type schema:DefinedTerm
164 sg:journal.1096890 schema:issn 0268-3369
165 1476-5365
166 schema:name Bone Marrow Transplantation
167 rdf:type schema:Periodical
168 sg:person.01001105007.49 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
169 schema:familyName Nasta
170 schema:givenName S D
171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001105007.49
172 rdf:type schema:Person
173 sg:person.01044042041.97 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
174 schema:familyName Stadtmauer
175 schema:givenName E
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97
177 rdf:type schema:Person
178 sg:person.01240050411.42 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
179 schema:familyName Ahmadi
180 schema:givenName T
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240050411.42
182 rdf:type schema:Person
183 sg:person.01342471137.57 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
184 schema:familyName Frey
185 schema:givenName N
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342471137.57
187 rdf:type schema:Person
188 sg:person.014567760612.40 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
189 schema:familyName Schuster
190 schema:givenName S J
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014567760612.40
192 rdf:type schema:Person
193 sg:person.016115210252.03 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
194 schema:familyName Goldstein
195 schema:givenName S C
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016115210252.03
197 rdf:type schema:Person
198 sg:person.0613365041.61 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
199 schema:familyName Loren
200 schema:givenName A W
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613365041.61
202 rdf:type schema:Person
203 sg:person.0707416147.15 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
204 schema:familyName Porter
205 schema:givenName D
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707416147.15
207 rdf:type schema:Person
208 sg:person.0722677225.98 schema:affiliation https://www.grid.ac/institutes/grid.25879.31
209 schema:familyName Svoboda
210 schema:givenName J
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722677225.98
212 rdf:type schema:Person
213 https://app.dimensions.ai/details/publication/pub.1076949215 schema:CreativeWork
214 https://doi.org/10.1002/cncr.11838 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052550962
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1046/j.1365-2141.2003.04140.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011769252
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1093/annonc/mdl127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018683246
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1093/oxfordjournals.annonc.a059155 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082434789
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1111/j.1365-2141.2010.08228.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1004342869
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1182/blood-2002-08-2476 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025513720
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1182/blood-2004-10-3883 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040043539
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1182/blood-2006-04-016725 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053696274
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1182/blood-2006-05-021113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001773472
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1182/blood-2008-03-147025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014062347
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1200/jco.1998.16.8.2780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083306001
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1200/jco.20.5.1288 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064202851
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1200/jco.2002.08.674 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203113
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1200/jco.2005.01.1825 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036898047
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1200/jco.2005.04.164 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024531918
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1200/jco.2005.08.133 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012126812
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1200/jco.2006.09.2403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045509899
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1200/jco.2008.16.8435 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053491476
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1200/jco.2008.17.1561 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036111565
251 rdf:type schema:CreativeWork
252 https://www.grid.ac/institutes/grid.25879.31 schema:alternateName University of Pennsylvania
253 schema:name Department of Medicine, University of Pennsylvania Philadelphia, Philadelphia, PA, USA
254 Division of Hematology/Oncology, Abramson Cancer Center, University of Pennsylvania Philadelphia, Philadelphia, PA, USA
255 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...